Beijing Houcheng Pharmaceutical Technology

Beijing Houcheng Pharmaceutical Technology is a professional Contract Research Organization (CRO) based in China, specializing in providing full-service clinical trial solutions. Founded in 2010, the company offers a broad range of services including clinical trial operation, Site Management Organization (SMO) support, medical writing, data management, and statistical analysis. Houcheng has established a robust network across hundreds of hospitals in China, supporting domestic and international pharmaceutical companies in therapeutic areas such as oncology, cardiology, and metabolic diseases. The company is recognized for its adherence to international quality standards and its ability to accelerate drug development timelines in the Chinese market. In 2021, the company secured Series A funding from Sherpa Healthcare Partners to further enhance its service offerings and technological infrastructure.